Abingdon, UK: OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2018 OBN Awards.

The Awards, which are in their 10th year, celebrate the best of UK life sciences – from outstanding scientific innovation within biotech, medtech, digital, synthetic biology, to the companies that support the industry and the fundraisers that make it happen.  This year’s event hosted an audience of over 250 life sciences industry leaders at the Oxford Examination Schools.

John Harris, CEO of OBN, said: “We received an outstanding number of entries this year so competition has been really tough.  All our winners and nominees this year are truly innovative and set a great example to the rest of the industry.  We have introduced several new categories this year to reflect industry trends. The turn-out and support we have received is a true reflection of how buoyant our industry is and I would like to thank our sponsors and supporters for helping us make the awards such a great success.”

The winners of the awards are:

Best Start-up Biotech, kindly sponsored by Novo Nordisk

Winner – IGEM Therapeutics

An immuno-oncology company focused on the development of IgE antibody drugs to fight cancer.

Best Emerging Biotech, kindly sponsored by World Courier

Winner – Blue Earth Diagnostics

A molecular imaging diagnostics company focused on the development and commercialisation of novel PET imaging agents.

Best Established Biotech, kindly sponsored by Horton International

Winner - Oxford BioMedica

Specialising in the development and commercialisation of gene-based medicines.

Best Diagnostic Medtech, kindly sponsored by Penningtons Manches

Winner – DNA Electronics

Breakthrough DNA analysis technology that brings patients the benefits of fast and insightful diagnostics.

Best Imaging Medtech, kindly sponsored by Blue Earth Diagnostics

Winner - Beamline Diagnostics

Developing a biopsy triaging system that can identify healthy and benign tissue specimens with high accuracy within seconds.

Best Innovative Medtech (non-Diagnostic or Imaging), kindly sponsored by James Cowper Kreston

Winner – Invizius

Developing H-Guard™ technology to reduce the side effects of hemodialysis in particular, cardiovascular complications.  

Best Implementation of Digital Technology for Healthcare

Winner - Ieso Digital Health

Providing online cognitive behavioural therapy (CBT) to treat a range of mental health conditions.

Best Specialist CRO

Winner - Diamond Pharma Services

A leading technical services and consulting group, providing expert support in particular to cell and gene therapy companies.

Best Sector Support Organisation

Winner – UnitDx

Catalysing activity in the scientific innovation community in Bristol through its dynamic facility for start-ups and SME’s.

Best Emerging Synthetic Biology Company, kindly sponsored by SynbiCITE

Winner – Evonetix

Revolutionising de novo gene synthesis to facilitate the fast-growing and exciting field of synthetic biology.

The BioSeed ‘One to Watch’ Award, kindly sponsored by Precision for Medicine, Oncology and Rare Disease

Winner - Pragma Therapeutics

Developing innovative therapeutics for the treatment of stress related disorders, in particular post-traumatic stress disorder, and hearing loss.

Special Recognition Award, kindly sponsored by MEPC Milton Park

Winner - James Noble, CEO of Adaptimmune and Deputy Chairman of GW Pharmaceuticals for his outstanding contribution to the biotech industry

Outstanding Achievement Award

Winner - GammaDelta Therapeutics

Developing pioneering targeted gamma delta T-cells immunotherapies for cancer and autoimmune disease.